PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
20-Apr-2026 Last Patient has Completed AlzeCure's Phase Ib Clinical Study with NeuroRestore ACD856 ACCESS Newswire
20-Apr-2026 Faron Pharmaceuticals Ltd: Holding(S) In Company ACCESS Newswire
20-Apr-2026 Faron Pharmaceuticals Ltd: Holding(S) In Company ACCESS Newswire
20-Apr-2026 Senzime Wins Expanded Contract Within Leading Southeastern US Hospital System ACCESS Newswire
20-Apr-2026 New Data from Investigator‑Initiated Study Evaluating Alligator Bioscience’s Mitazalimab to Be Presented at AACR Annual Meeting 2026 ACCESS Newswire
20-Apr-2026 Genflow Biosciences PLC Announces Strategic Technology Collaboration ACCESS Newswire
20-Apr-2026 Who Does the Best Deep Plane Facelift in Florida? ACCESS Newswire
19-Apr-2026 4/20 and the Future of Cannabis Medicine: Why Botanical Therapies Must Meet Real Scientific Standards ACCESS Newswire
19-Apr-2026 Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock ACCESS Newswire
19-Apr-2026 Inocras and Broad Institute Researchers Present New TCGA Whole-Genome Cancer Insights, Accelerating Discovery in Cancer Genomics Businesswire
18-Apr-2026 Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments Businesswire
18-Apr-2026 Baron & Budd Finalizes $774 Million Settlement With Albertsons in Nationwide Opioid Litigation Businesswire
18-Apr-2026 CORRECTING and REPLACING Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants Businesswire
18-Apr-2026 Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules Businesswire
17-Apr-2026 SAGA Diagnostics to Present New Pathlight™ MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026 Businesswire
17-Apr-2026 Orum Therapeutics Presents New Preclinical Data at AACR 2026 on ORM-1153, a CD123-Targeting Degrader-Antibody Conjugate, Highlighting Broad Activity in Acute Myeloid Leukemia and the Potential for Improved Efficacy and Tolerability Businesswire
17-Apr-2026 SingleCell Biotechnology Presents Data at AACR Annual Meeting Demonstrating High-Throughput Single-Cell Assay Linking Clonal Growth Phenotypes to Molecular Profiles Businesswire
17-Apr-2026 Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 Businesswire
17-Apr-2026 OncoNano to Present New Preclinical Data at AACR 2026 Highlighting Effective Tumor Delivery Enabled by ON-BOARD™ Platform Businesswire
17-Apr-2026 Salubris Biotherapeutics Presents Phase 1/2 Dose Escalation and Expansion Cohort Data for JK06, 5T4-Targeted Antibody Drug Conjugate, at the American Association for Cancer Research Annual Meeting Businesswire